The document archive below contains only a partial list of the comment submissions.
Click here to view all the submissions in
Text comments submitted by individuals can be found on Pharma Marketing Blog.



This page was created so that individuals, organizations, and companies can share the comments that they are planning to submit or have aleady submitted to the FDA regarding the use of the Internet and Social Media for promoting FDA-regulated products. Although the official deadline for comment submission is February 28, in a recent interview conducted with DDMAC's Jean-Ah Kang she explained that they would still accept comments past this deadline. Below are some helpful links regarding comment submission:

Feel free to provide your perspective on the comments submitted by going to the following Google Spreadsheet. Share this page with others. If you use twitter, include the hashtag #FDASM when discussing this topic.

Created by Ignite Health | @skypen | copyright 2010
All logos on this site have been used with expressed permission of their respective owners.

This Web site has been created as a free service to the healthcare communications industry and its related stakeholders that are interested in following the news, blogs, and tweets regarding the FDA public hearings on the use of the Internet and Social Media for health-related communications, as well as the process to developing guidance for manufacturers of FDA-regulated products. The feeds on this site are being pulled dynamically from a variety of publicly-available sources, and the content of the feeds do not necessarily represent the views of, and should not be attributed to, either the creator of this site or the companies and individuals whose logos appear on this site as a sign of support for this event. This site is not affiliated with or endorsed by the Food & Drug Administration.